Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rullmann

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Neuropharmacology|April 26, 2016
The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography studyPhilipp Hinderberger, Michael Rullmann, Mandy Drabe, et al.
European Journal of Radiology|September 11, 2020
Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI studySolveig Tiepolt, Michael Rullmann, Thies H Jochimsen, et al.
Bioelectronic Medicine|February 26, 2025
Long COVID - a critical disruption of cholinergic neurotransmission?Marco Leitzke, Donald Troy Roach, Swen Hesse, et al.
Brain Communications|November 25, 2024
Motor learning is modulated by dopamine availability in the sensorimotor putamenChristoph Muehlberg, Sophia Goerg, Michael Rullmann, et al.
Brain Sciences|July 27, 2022
Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)Jue Huang, Nicole Mauche, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2020
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertensionArmin Frille, Michael Rullmann, Georg-Alexander Becker, et al.
Frontiers in Nuclear Medicine|March 6, 2026
Rethinking dynamics: static amino acid PET parameters vs. dynamic amino acid PET parameters for the detection of tumor progression in patients with post-treatment gliomaDylan Henssen, Michael Rullmann, Andreas Schildan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2016
Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's diseaseTobias Tuszynski, Michael Rullmann, Julia Luthardt, et al.
The European Journal of Neuroscience|August 14, 2016
Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non-obese individualsFranziska Zientek, Karsten Winter, Astrid Müller, et al.
Scientific Reports|December 8, 2020
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesityRico Grundmann, Michael Rullmann, Julia Luthardt, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Neuropharmacology|April 26, 2016
The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography studyPhilipp Hinderberger, Michael Rullmann, Mandy Drabe, et al.
European Journal of Radiology|September 11, 2020
Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI studySolveig Tiepolt, Michael Rullmann, Thies H Jochimsen, et al.
Bioelectronic Medicine|February 26, 2025
Long COVID - a critical disruption of cholinergic neurotransmission?Marco Leitzke, Donald Troy Roach, Swen Hesse, et al.
Brain Communications|November 25, 2024
Motor learning is modulated by dopamine availability in the sensorimotor putamenChristoph Muehlberg, Sophia Goerg, Michael Rullmann, et al.
Brain Sciences|July 27, 2022
Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)Jue Huang, Nicole Mauche, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2020
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertensionArmin Frille, Michael Rullmann, Georg-Alexander Becker, et al.
Frontiers in Nuclear Medicine|March 6, 2026
Rethinking dynamics: static amino acid PET parameters vs. dynamic amino acid PET parameters for the detection of tumor progression in patients with post-treatment gliomaDylan Henssen, Michael Rullmann, Andreas Schildan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2016
Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's diseaseTobias Tuszynski, Michael Rullmann, Julia Luthardt, et al.
The European Journal of Neuroscience|August 14, 2016
Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non-obese individualsFranziska Zientek, Karsten Winter, Astrid Müller, et al.
Scientific Reports|December 8, 2020
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesityRico Grundmann, Michael Rullmann, Julia Luthardt, et al.
Pageof 9